Department of Medicine

Faculty

Herwig-Ulf Meier-Kriesche, M.D.

Dr. Meier-Kriesche is currently Professor of Medicine and Clinical Director of Renal Transplant in the Department of Medicine. He received his medical degree from the University of Perugia in Italy, and did his internal medicine training with a subspecialty in nephrology at the University of Cagliari in Italy. He then spent two years as a research fellow in transplantation pharmacology and immunology in the division of Immunology and Organ Transplantation at the University of Texas in Houston. He went on to complete a Nephrology fellowship in the Division of Nephrology at the University of Texas at Houston, and a transplant nephrology fellowship at the University of Michigan, where he was recruited to remain on faculty. Dr. Meier-Kriesche joined the University of Florida in 2001. During his career he has received numerous prestigious awards for his research in renal transplantation from the American Society of Transplantation, The American Society of Geriatrics, Wyeth-Ayerst Pharmaceuticals and Sangstat Pharmaceuticals. He is recognized nationally and internationally for his research in outcomes of kidney transplantation.

Publications (through Pubmed)

Research Interest

Dr. Meier-Kriesche’s research interests include study design and outcomes research in renal transplantation, immunosuppressive protocols in transplantation, and the pharmacokinetics of immunosuppressive medications. He is particularly renowned for his studies on the use, metabolism, and complications of immunosuppressive drugs in elderly renal transplant recipients.

Dr. Meier-Kriesche’s other interests include the effect of immunosuppressive protocols on chronic allograft failure, and the identification of factors affecting transplant organ and patient survival. His work in pharmacokinetics has been instrumental and widely influential in establishing the proper dosing strategies for the newer immunosuppressive agents sirolimus and mycophenolate mofetil.